secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0000950170-24-010475
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences stockholders approve reverse stock split; Board sets ratio at 1-for-12
--------------------------------------------------------------------------------

- Stockholders approved a range of 1-for-7 to 1-for-17 reverse stock split; Board selected 1-for-12 ratio.
- Approval of share issuance to Gilead Sciences under October 2023 Stock Purchase Agreement (16.2M votes for).
- Reverse split expected to be effectuated as soon as practicable after the January 31, 2024 special meeting.
- Adjournment proposal approved with 28M votes for, 9.7M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/0000950170-24-010475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000095017024010475/asmb-20240131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-010475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer